PRESS RELEASE published on 05/28/2024 at 18:00, 2 years 1 month ago Quadpack 2023 results: Strong operating performance amid market softness Quadpack Industries achieved a turnover of €129 million in 2023, with increased EBITDA, strategic financing deal, and organizational restructuring. New business strategy focuses on profitability and sustainability EBITDA Turnover Strategic Financing Quadpack Industries Organizational Restructuring
BRIEF published on 04/25/2024 at 08:35, 2 years 2 months ago Quadpack Announces EUR 50,000 Contribution to its Liquidity Contract with Invest Securities Liquidity Contract Euronext Growth INVEST SECURITIES Financial Stability Quadpack Industries
BRIEF published on 04/25/2024 at 08:35, 2 years 2 months ago Quadpack annonce une contribution de 50 000 EUR à son contrat de liquidité avec Invest Securities Contrat De Liquidité Stabilité Financière Euronext Croissance Industries Quadpack Investir Des Titres
PRESS RELEASE published on 04/25/2024 at 08:30, 2 years 2 months ago Quadpack makes EUR 50,000 cash injection into liquidity contract with Invest Securities Quadpack Industries contributes €50,000 to liquidity contract with Invest Securities to balance cash and shares on Euronext Growth stock exchange in Paris, in line with AMF Decision Liquidity Contract Euronext Growth INVEST SECURITIES Quadpack Industries AMF Decision
Published on 07/22/2026 at 15:00, 6 hours 7 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 6 hours 7 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 6 hours 32 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 6 hours 37 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 20:44, 23 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 20:08, 59 minutes ago EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 19:35, 1 hour 31 minutes ago Stabilus SE: Invitation to a web conference on Q3 FY2026 results on August 3, 2026
Published on 07/22/2026 at 19:29, 1 hour 37 minutes ago EQS-Adhoc: Stabilus SE: Profit from operating activities and profit for the period significantly higher, adjusted FCF lower than in Q3 of the prior year; full-year forecast specified within the original ranges
Published on 07/22/2026 at 18:19, 2 hours 48 minutes ago Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Published on 07/22/2026 at 18:19, 2 hours 48 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 3 hours 22 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:45, 3 hours 22 minutes ago Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Published on 07/22/2026 at 17:40, 3 hours 27 minutes ago Report on share repurchases from 15 to 21 July 2026
